Analysts Have Conflicting Sentiments on These Healthcare Companies: Dexcom (NASDAQ: DXCM) and ACADIA Pharmaceuticals (NASDAQ: ACAD)

By Jason Carr

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Dexcom (DXCMResearch Report) and ACADIA Pharmaceuticals (ACADResearch Report).

Dexcom (DXCM)

In a report released today, Robbie Marcus from J.P. Morgan maintained a Buy rating on Dexcom, with a price target of $215.00. The company’s shares closed last Monday at $153.12.

According to TipRanks.com, Marcus is a 4-star analyst with an average return of 13.1% and a 58.8% success rate. Marcus covers the Healthcare sector, focusing on stocks such as Baxter International, Boston Scientific, and SmileDirectClub.

Currently, the analyst consensus on Dexcom is a Strong Buy with an average price target of $196.67, representing a 27.7% upside. In a report released yesterday, Piper Jaffray also maintained a Buy rating on the stock with a $200.00 price target.

See today’s analyst top recommended stocks >>

ACADIA Pharmaceuticals (ACAD)

J.P. Morgan analyst Cory Kasimov maintained a Hold rating on ACADIA Pharmaceuticals today and set a price target of $35.00. The company’s shares closed last Monday at $40.99, close to its 52-week high of $44.85.

According to TipRanks.com, Kasimov is a 4-star analyst with an average return of 4.3% and a 45.0% success rate. Kasimov covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, Global Blood Therapeutics, and Alexion Pharmaceuticals.

ACADIA Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $54.00, which is a 29.4% upside from current levels. In a report issued on October 23, Oppenheimer also initiated coverage with a Hold rating on the stock with a $44.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.